Literature DB >> 11989663

Antibodies for neoplastic disease solid tumors.

Ian T W Matthews1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11989663     DOI: 10.1385/MB:21:1:091

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


× No keyword cloud information.
  28 in total

1.  Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin.

Authors:  A E Frankel; J H Laver; M C Willingham; L J Burns; J H Kersey; D A Vallera
Journal:  Leuk Lymphoma       Date:  1997-07

Review 2.  Ovarian carcinoma therapy with monoclonal antibodies.

Authors:  S Canevari; S Miotti; F Bottero; O Valota; M I Colnaghi
Journal:  Hybridoma       Date:  1993-10

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.

Authors:  F H Valone; P A Kaufman; P M Guyre; L D Lewis; V Memoli; Y Deo; R Graziano; J L Fisher; L Meyer; M Mrozek-Orlowski
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

5.  Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.

Authors:  J A Siegel; D A Pawlyk; R E Lee; N L Sasso; J A Horowitz; R M Sharkey; D M Goldenberg
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

6.  Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.

Authors:  S E Order; G B Stillwagon; J L Klein; P K Leichner; S S Siegelman; E K Fishman; D S Ettinger; T Haulk; K Kopher; K Finney
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

7.  Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7.

Authors:  L G Durrant; T J Buckley; G W Denton; J D Hardcastle; H F Sewell; R A Robins
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

8.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

Authors:  G Riethmüller; E Schneider-Gädicke; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; H Pichlmaier; H Hirche; R Pichlmayr
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

9.  Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.

Authors:  H P Kalofonos; T R Pawlikowska; A Hemingway; N Courtenay-Luck; B Dhokia; D Snook; G B Sivolapenko; G R Hooker; C G McKenzie; P J Lavender
Journal:  J Nucl Med       Date:  1989-10       Impact factor: 10.057

10.  Radioimmunotherapy of gastrointestinal cancer and glioblastomas.

Authors:  P Riva; V Tison; A Arista; C Sturiale; G Franceschi; N Riva; M Casi; G Moscatelli; F Campori; A Spinelli
Journal:  Int J Biol Markers       Date:  1993 Jul-Sep       Impact factor: 3.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.